Recap: Joint Webinar of Melchers China and Cisema on MedTech Market in China
China is the second-largest medical device market globally, which, driven by a focus on new and innovative products, continues to outgrow mature markets. Imported medical devices, especially from the DACH region, enjoy high appreciation from Chinese customers. However, the fast-growing market is also dynamic and complex. A changing regulatory framework as well as government reform and development programs impact the industry simultaneously, leading to price pressure and increased domestic competition. How to adjust one’s China strategy to address the regulatory developments and capitalize on the market opportunities has become a hot topic recently.
For an in-depth analysis and sharing of insights into these key considerations, on September 12, Melchers China organized a webinar together with Cisema, a China regulatory affairs turnkey solution provider for medical device and IVD products. Five experts with extensive hands-on experience in China’s MedTech and healthcare sectors provided the participating medical device manufacturers with the latest market information, guidance on registration as well as strategy recommendations for distribution and localization.
Click on the video below to view the webinar recording (in German language):
For a copy of the slide deck, please reach out to [email protected]
For more information about our offerings for healthcare companies, please visit our website Healthcare • Melchers China (melchers-china.com)
